Indeed, it has been demonstrated that DLEU1 and DLEU2 and their neighboring tumor-suppressor genes are epigenetically deregulated in the majority of CLL patients. This evidence concerns the gene DLEU2 and B-cell chronic lymphocytic leukemia.